参考文献/References:
[1].Zhou YMa J,Zhu W,et al.Efficacy and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation across BMI categories:a systematic review and meta-analysis[J].Am J Cardiovasc Drug,2019,20(1):51-60.
[2].Goriacko P,Veltri KT.Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation[J].Eur J Haematol,2018,100(5):488-493.
[3].Yoshida Y,Watarai M,Fujii K.Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation:results of the Japanese subgroup of the RE-CIRCUIT trial[J].J Arrhythm,2018,34(2):148-157.
[4].Pratt NL,Ramsay E,Ellett LMK,et al.Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin:a sequential cohort study[J].BMJ Open,2019,9(5):e026486.
[5].陈文文党和勤耿涛等影响房颤患者华法林抗凝控制质量的因素分析[J]中国医院药学杂志2016,36(24):2191-2194.
[6].Inoue H,?Atarashi H,?Kodani E,et al.Regional differences in frequency of warfarin therapy and thromboembolism in Japanese patients with non-valvular atrial fibrillation—Analysis of the J-RHYTHM Registry[J].Circ J,2016,80(7):1548-1555.
[7].Makar-Au?perger K,Kr?elj K,Lovri? Ben?i? M,et al.Warfarin dosing according to the genotype-guided algorithm is most beneficial in patients with atrial fibrillation:a randomized parallel group trial[J].Ther Drug Monit,2018,40(3):362-368.
[8].黄从新张澍黄德嘉等代表中华医学会心电生理和起搏分会、中国医师协会心律学专业委员会心房颤动防治专家工作委员会心房颤动目前的认识和治疗建议-2015[J]中国心脏起搏与心电生理杂志2015,29(5):377-434.
[9].苏轮薛俊仙胡超等436例老年心房颤动病人的临床特点分析[J]中西医结合心脑血管病杂志2017,15(20):2616-2618.
[10].Rosendaal FR,Cannegieter SC,van der Meer FJ,et al.A method to determine the optimal intensity of oral anticoagulant therapy[J].Thromb Haemost,1993,69(3):236-239.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(8):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(8):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]王鹏举,综述,陈茂,等.华法林相关性肾病[J].心血管病学进展,2016,(2):167.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.018]
WANG Pengju,CHEN Mao.Warfarin-related Ephropathy[J].Advances in Cardiovascular Diseases,2016,(8):167.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.018]
[6]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[7]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[8]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(8):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[9]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(8):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[10]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(8):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]